p-Toluenesulfonic acid → HCID 24986498, compound
Reaction equation
[CH2:1]([N:8]1[CH2:42][CH2:41][C:11]2([N:15]([C:16]3[CH:21]=[C:20]([F:22])[CH:19]=[CH:18][C:17]=3[C:23]3[CH:28]=[CH:27][C:26]([S:29]([CH3:32])(=[O:31])=[O:30])=[CH:25][CH:24]=3)[C:14](=[O:33])[N:13]=[C:12]2[NH:34][CH2:35][CH:36](OC)OC)[CH2:10][CH:9]1[CH3:43])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1(C)C=CC(S(O)(=O)=O)=CC=1>C1(C)C=CC=CC=1>[CH2:1]([N:8]1[CH2:42][CH2:41][C:11]2([C:12]3=[N:34][CH:35]=[CH:36][N:13]3[C:14](=[O:33])[N:15]2[C:16]2[CH:21]=[C:20]([F:22])[CH:19]=[CH:18][C:17]=2[C:23]2[CH:28]=[CH:27][C:26]([S:29]([CH3:32])(=[O:30])=[O:31])=[CH:25][CH:24]=2)[CH2:10][CH:9]1[CH3:43])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 110 °C
Procedure
To a solution of 8-benzyl-4-[(2,2-dimethoxyethyl)amino]-1-[4-fluoro-4′-(methylsulfonyl)biphenyl-2-yl]-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one (50 mg, 0.08 mmol) in toluene (2.0 ml) was added p-toluenesulfonic acid (20 mg, 0.01 mmol). The reaction was sealed and allowed to stir at 110° C. The reaction was purified via reverse phase chromatography and neutralized with sodium bicarbonate. The product was extracted with EtOAc, dried over sodium sulfate, filtered, and concentrated in vacuo to yield the title compound as cis and trans mixture-1′-benzyl-6-[4-fluoro-4′-(methylsulfonyl)biphenyl-2-yl]-2′-methylspiro[imidazo[1,5-a]imidazole-7,4′-piperidin]-5(6H)-one. LCMS (M+H) 544.9. 1H NMR (400 MHz, CD3OD) δ 7.98 (m, 1H), 7.89 (m, 1H), 7.66 (m, 3H), 7.55 (m, 1H), 7.46 (m, 1H), 7.40 (dt, J=8.8, 2.8 Hz, 0.5H), 7.32 (dt, J=9.2, 2.8 Hz, 0.5H), 7.22 (m, 5H), 6.91 (m, 0.5H), 6.79 (m, 0.5H), 4.10 (m, 1H), 3.12 (s, 1.5H), 3.06 (s, 1.5H), 3.02 (s, 1H), 2.81 (m, 1H), 2.71-2.40 (m, 2H), 2.04-1.85 (m, 1H), 1.78-1.57 (m, 3H), 1.32 (s, 3H).
Workup
- customThe reaction was sealed
- customThe reaction was purified via reverse phase chromatography
- extractionThe product was extracted with EtOAc
- dry with materialdried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-e8d84d5acc40487bacd8af61f27898dc
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08377954B2
Reaction notes
Loading…